Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Liposomes
Researchers from University libre of Bruxelles report recent findings in liposomes
June 25th, 2008
Scientists discuss in 'DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4' new findings in liposomes. According to a study from Charleroi, Belgium, "DiC14-amidine cationic liposomes were recently shown to promote Th1 responses when mixed with allergen. To further define the mode of action of diC14-amidine as potential vaccine adjuvant, we characterized its effects on mouse and human myeloid dendritic cells (DC)." "First, we observed that, as compared with two other cationic liposomes, only diC14-amidine liposomes induced the production of IL-12p40 and TNF-alpha by mouse bone marrow-derived DC. DiC14-amidine liposomes also...
Source: Vaccine Weekly (2008-06-25)
|
